Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Krukenberg Tumor × Gynecologic × Clear all

Phase

Phase 1/2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 221 Uterine Cervical Neoplasms 181 Fallopian Tube Neoplasms 91 Carcinoma, Ovarian Epithelial 84 Endometrial Neoplasms 73 Neoplasms 37 Uterine Cervical Dysplasia 35 Papillomavirus Infections 35 Breast Neoplasms 26 Peritoneal Neoplasms 25 Vulvar Neoplasms 23 Condylomata Acuminata 22 Vaginal Neoplasms 18 Recurrence 16 Testicular Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Burkitt Lymphoma 12 Brenner Tumor 12 Primary Myelofibrosis 11 Multiple Myeloma 11 Lymphoma, Non-Hodgkin 11 Lymphoma, Mantle-Cell 11 Lymphoma, Large-Cell, Immunoblastic 11 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Follicular 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Chronic-Phase 11 Leukemia, Myeloid, Accelerated Phase 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Blast Crisis 11

Interventions

Laparotomy 1 Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡